These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9137901)

  • 1. Efficacy of low-dose pravastatin in patients with mild hyperlipidemia associated with type II diabetes mellitus.
    Krempf M; Berthezène F; Wemeau JL; Moinade S; Desriac I; Amelineau E; Passa P
    Diabetes Metab; 1997 Apr; 23(2):131-6. PubMed ID: 9137901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multinational study of the effects of low-dose pravastatin in patients with non-insulin-dependent diabetes mellitus and hypercholesterolemia. Pravastatin Multinational Study Group for Diabetes.
    Behounek BD; McGovern ME; Kassler-Taub KB; Markowitz JS; Bergman M
    Clin Cardiol; 1994 Oct; 17(10):558-62. PubMed ID: 8001304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.
    Gentile S; Turco S; Guarino G; Sasso CF; Amodio M; Magliano P; Salvatore T; Corigliano G; Agrusta M; De Simone G; Gaeta I; Oliviero B; Torella R
    Diabetes Obes Metab; 2000 Dec; 2(6):355-62. PubMed ID: 11225965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with type 2 diabetes mellitus.
    Rustemeijer C; Schouten JA; Voerman HJ; Hensgens HE; Donker AJ; Heine RJ
    Diabetes Metab Res Rev; 2000; 16(2):82-7. PubMed ID: 10751747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia.
    Raskin P; Ganda OP; Schwartz S; Willard D; Rosenstock J; Lodewick PA; Cressman MD; Phillipson B; Weiner B; McGovern ME
    Am J Med; 1995 Oct; 99(4):362-9. PubMed ID: 7573090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
    Lewis JH; Mortensen ME; Zweig S; Fusco MJ; Medoff JR; Belder R;
    Hepatology; 2007 Nov; 46(5):1453-63. PubMed ID: 17668878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study.
    Tikkanen MJ; Laakso M; Ilmonen M; Helve E; Kaarsalo E; Kilkki E; Saltevo J
    Diabetes Care; 1998 Apr; 21(4):477-81. PubMed ID: 9571327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pravastatin and risk factor modification in patients with moderate primary hypercholesterolaemia.
    Morris R; Robinson G; Tilyard M; Gurr E
    N Z Med J; 1996 Aug; 109(1028):319-22. PubMed ID: 8816723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia. French Fluvastatin Study Group.
    Jacotot B; Benghozi R; Pfister P; Holmes D
    Am J Cardiol; 1995 Jul; 76(2):54A-56A. PubMed ID: 7604799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of low-dose pravastatin and squalene, alone and in combination, in elderly patients with hypercholesterolemia.
    Chan P; Tomlinson B; Lee CB; Lee YS
    J Clin Pharmacol; 1996 May; 36(5):422-7. PubMed ID: 8739021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy and tolerability of pravastatin in hypercholesterolemia in patients with non-insulin-dependent diabetes mellitus. Hyogo Pravastatin Study Group.
    Kazumi T; Yoshino G; Ishida Y; Iwatani I; Morita S; Tateiwa M; Kasuga M
    Diabetes Res Clin Pract; 1995 Jan; 27(1):61-8. PubMed ID: 7781495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia.
    Diabetes Atorvastin Lipid Intervention (DALI) Study Group
    Diabetes Care; 2001 Aug; 24(8):1335-41. PubMed ID: 11473066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia.
    Milani M; Cimminiello C; Merlo B; Lorena M; Arpaia G; Bonfardeci G
    Am J Cardiol; 1995 Jul; 76(2):51A-53A. PubMed ID: 7604798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia.
    Malini PL; Ambrosioni E; De Divitiis O; Di Somma S; Rosiello G; Trimarco B
    Clin Ther; 1991; 13(4):500-10. PubMed ID: 1934003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary effects of pravastatin and nicotinic acid in the treatment of combined hyperlipidaemia in diabetic and non-diabetic patients.
    Tsalamandris C; Panagiotopoulos S; Sinha A; Cooper ME; Jerums G
    J Cardiovasc Risk; 1994 Oct; 1(3):231-9. PubMed ID: 7621303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia.
    Bertolini S; Bon GB; Campbell LM; Farnier M; Langan J; Mahla G; Pauciullo P; Sirtori C; Egros F; Fayyad R; Nawrocki JW
    Atherosclerosis; 1997 Apr; 130(1-2):191-7. PubMed ID: 9126664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of simvastatin and pravastatin in patients with primary hypercholesterolemia (multicountry comparative study). The European Study Group.
    Am J Cardiol; 1992 Nov; 70(15):1281-6. PubMed ID: 1442579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pravastatin in patients with primary hyperlipidaemia.
    Mafauzy M; Mokhtar M; Wan Mohamad WB; Musalmah M
    Med J Malaysia; 1995 Sep; 50(3):272-7. PubMed ID: 8926908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial combination therapy with metformin plus colesevelam improves lipoprotein particles in patients with early type 2 diabetes mellitus.
    Goldberg RB; Rosenson RS; Hernandez-Triana E; Misir S; Jones MR
    J Clin Lipidol; 2012; 6(4):318-24. PubMed ID: 22836068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.